The present disclosure provides peptoid-based chelating ligands, corresponding cyclic peptoids, and methods of making thereof. Functional groups may be tailored for high metal binding affinity and selectivity. The side chains of a cyclic peptoid according to the present disclosure may be selected based on, for example, high affinity for actinide or other metal ions, selectivity for actinide or other metal ions, the ability to recover a metal once it is bound to the peptoid, and whether the overall peptoid should be hydrophobic or hydrophilic. Unlike siderophores, peptoid-based chelating ligands of the present disclosure are not readily hydrolyzed under physiological conditions. Therefore, peptoid-based chelating ligands may be, for example, used to treat actinide (e.g., iron and lead) poisoning in vivo. Moreover, peptoid-based chelating ligands of the present disclosure may be used for medical imaging, chelation therapy, drug delivery, and separation technologies, for example.
本公开提供基于肽酰胺的螯合
配体、相应的环状肽酰胺及其制备方法。功能基团可以根据高
金属结合亲和力和选择性进行定制。根据本公开的环状肽酰胺的侧链可以根据,例如,对
锕系元素或其他
金属离子的高亲和力、对
锕系元素或其他
金属离子的选择性、一旦
金属与肽酰胺结合后是否能够回收
金属,以及整体肽酰胺是疏
水性还是亲
水性来进行选择。与
铁载体不同,本公开的基于肽酰胺的螯合
配体在生理条件下不容易
水解。因此,基于肽酰胺的螯合
配体可以用于治疗体内的
锕系元素(例如
铁和
铅)中毒。此外,本公开的基于肽酰胺的螯合
配体可以用于医学成像、螯合疗法、药物输送和分离技术等领域。